Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IXJ vs. SWHFX: which is better?

Bottom line

IXJ vs SWHFX: the short answer

IXJ (iShares Global Healthcare ETF) and SWHFX (Schwab Health Care Fund) share a meaningful slice of their top holdings — about 76% by weight.

IXJ is cheaper at 0.38% vs 0.8% — a difference of $42 a year per $10,000 invested.

Over five years, SWHFX returned +6.5% a year vs +6.4% for IXJ.

Updated Nov 19, 2026

IXJ vs SWHFX side by side

IXJSWHFX
TypeETFMutual fund
Fund familyiSharesSchwab
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.38%0.8%
Annual cost per $10k$38$80
10-yr cost on $10k (prospectus)$480$990
Max front loadNone—
12b-1 fee0%0%
1-yr return+14.9%+15.9%
5-yr return (annualized)+6.4%+6.5%
10-yr return (annualized)+8.2%+8.1%
Best quarter+13.6%+15.3%
Worst quarter−11.8%−12.1%
Net assets (fund)$3.8B$642.3M
Number of holdings12480
Portfolio turnover2%41%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIXJSWHFXDifference
2025+14.9%+15.9%−1.1%
2024+0.6%+0.1%+0.5%
2023+3.5%+0.7%+2.8%
2022−4.7%−4.7%−0.0%
2021+19.5%+23.3%−3.8%
2020+12.5%+12.9%−0.4%
2019+23.4%+17.6%+5.7%
2018+2.9%+4.0%−1.1%
2017+20.3%+20.2%+0.1%
2016−6.2%−4.4%−1.8%

Source: Fund prospectus bar charts

Holdings overlap

18 of IXJ's top 25 holdings also appear in SWHFX's top 25.

Shared top holdings
HoldingIXJSWHFX
Eli Lilly And Company10.93%13.92%
Johnson & Johnson7.04%6.94%
Abbvie Inc.5.12%5.81%
Unitedhealth Group Incorporated4.40%4.74%
Merck & Co., Inc.4.12%4.98%
Roche Holding AG3.75%2.29%
Novartis AG3.71%2.92%
Amgen Inc.2.54%2.58%
Thermo Fisher Scientific Incorporated2.42%2.16%
Abbott Laboratories2.05%1.60%
Gilead Sciences, Inc.2.04%3.24%
Vertex Pharmaceuticals Incorporated1.64%1.89%
Danaher Corporation1.56%1.47%
Bristol-myers Squibb Company1.53%2.44%
Stryker Corporation1.41%2.11%

Source: SEC Form N-PORT

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

SWHFX top 10

  1. Eli Lilly & Co — 13.92%
  2. Johnson & Johnson — 6.94%
  3. AbbVie Inc — 5.81%
  4. Merck & Co Inc — 4.98%
  5. UnitedHealth Group Inc — 4.74%
  6. Gilead Sciences Inc — 3.24%
  7. Novartis AG — 2.92%
  8. Amgen Inc — 2.58%
  9. Bristol-Myers Squibb Co — 2.44%
  10. Medtronic PLC — 2.29%

FAQ

What is the difference between IXJ and SWHFX?
IXJ (iShares Global Healthcare ETF) and SWHFX (Schwab Health Care Fund) share a meaningful slice of their top holdings — about 76% by weight. IXJ is cheaper at 0.38% vs 0.8% — a difference of $42 a year per $10,000 invested.
Which is cheaper, IXJ or SWHFX?
IXJ has the lower expense ratio (0.38%).
Should I own both IXJ and SWHFX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.